Literature DB >> 3108018

The effect of recombinant interferon-gamma on human monocyte-derived macrophages.

T W Jungi, P G Lerch, M Brcic.   

Abstract

The effect of recombinant interferon-gamma (rIFN-gamma) on human macrophage functions was studied, using monocytes which had matured to macrophages within hydrophobic containers. Following exposure to rIFN-gamma, the number of surface-expressed specific IgG-binding sites was increased. This increase was restricted to high-affinity Fc receptors (FcR), however; low-affinity FcR were not increased in number. Exposure to rIFN-gamma led to an enhanced chemiluminescence (CL) signal in the presence of luminol and a variety of respiratory burst stimuli, such as zymosan, phorbol 12-myristate 13-acetate or IgG-sensitized sheep erythrocytes (EA). In contrast, phagocytosis of EA was markedly depressed in rIFN-gamma-treated cells. Both increase in CL response and decrease in phagocytic activity were manifest after 1 day of treatment and were more pronounced after 2 days. While 5 U/ml of rIFN-gamma was an insufficient dose, 50 to 5000 U/ml yielded significant dose-dependent changes in both functional assays. Thus, using rIFN-gamma as a biological response-modifier, FcR expression and FcR-mediated CL can be dissociated from FcR-mediated phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108018     DOI: 10.1002/eji.1830170526

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Suppression by human recombinant gamma interferon of in vitro macrophage nonopsonic and opsonic phagocytosis and killing.

Authors:  D P Speert; L Thorson
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Gamma interferon treatment in vivo provokes accumulation of activated monocytes in the venous circulation of rats.

Authors:  B Steiniger; D Schröder; R Lück; L Luciano; P H van der Meide
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

3.  Augmentation of the human monocyte/macrophage chemiluminescence response during short-term exposure to interferon-gamma and tumour necrosis factor-alpha.

Authors:  L M Kumaratilake; A Ferrante; E J Bates; I C Kowanko
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

4.  Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.

Authors:  S J Rüegg; T W Jungi
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

5.  Effect of gamma interferon on expression of Fc gamma receptors in monocytes of newborn infants and adults.

Authors:  K D Fairchild; R G Hudson; S D Douglas; S E McKenzie; R A Polin
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

6.  Role of interferon-gamma on the in vivo expression of functional interleukin-2 receptors by murine macrophages.

Authors:  B Dugas; L Friteau; H Schellekens; D Lando; C Damais
Journal:  Inflammation       Date:  1991-06       Impact factor: 4.092

7.  Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors.

Authors:  L Maródi; S Schreiber; D C Anderson; R P MacDermott; H M Korchak; R B Johnston
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

8.  Recombinant human migration inhibitory factor has adjuvant activity.

Authors:  W Y Weiser; L M Pozzi; R G Titus; J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

9.  Interferon-gamma treatment impairs Fc receptor type II-mediated phagocytosis of human macrophages by a post-receptor-binding mechanism.

Authors:  T W Jungi; M Brcic; C Leutwyler; H Pfister; M O Spycher
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.